These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13654006)

  • 1. Duration of seroimmunity after injection with ultraviolet-irradiated poliomyelitis vaccine; role of booster inoculations.
    WOLF AM; SHAUGHNESSY HJ; JANOTA M; CHAPMAN JW; CHURCH RE; MOORE M
    J Am Med Assoc; 1959 Jun; 170(6):650-2. PubMed ID: 13654006
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of booster inoculations on the serologic status of children vaccinated with poliomyelitis vaccine.
    BROWN GC
    Am J Public Health Nations Health; 1955 Nov; 45(11):1401-8. PubMed ID: 13258901
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity of poliomyelitis vaccine prepared with ultraviolet irradiation and mild heat.
    SHAUGHNESSY HJ; WOLF AM; JANOTA M; NEAL J; OPPENHEIMER F; MILZER A; NAFTULIN H; MORRISSEY RA
    Proc Soc Exp Biol Med; 1957 Jun; 95(2):251-5. PubMed ID: 13441701
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity studies in human subjects of trivalent tissue culture poliomyelitis vaccine inactivated by ultraviolet irradiation.
    MILZER A; LEVINSON SO; SHAUGHNESSY HJ; JANOTA M; VANDERBOOM K; OPPENHEIMER F
    Am J Public Health Nations Health; 1954 Jan; 44(1):26-33. PubMed ID: 13114481
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody response and survival following booster injections of poliomyelitis (killed-virus) vaccine.
    BATSON R; CHRISTIE A; CHEATHAM WJ; MICHAL ML; SLEIGHT GW
    Pediatrics; 1962 Jan; 29():116-20. PubMed ID: 13865768
    [No Abstract]   [Full Text] [Related]  

  • 6. [2 1/2 Years of antipoliomyelitis vaccination (Lepine vaccine) at the Institut Pasteur hospital. Immunological results. Significance of the booster injection].
    MARTIN R; ROGER F; DAMAS JP; ROGER A
    Ann Inst Pasteur (Paris); 1959 Dec; 97():757-79. PubMed ID: 14421731
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity, in children, of ultraviolet-treated poliomyelitis vaccine.
    WOLF AM; SHAUGHNESSY HJ; CHURCH RE; MILZER A; JANOTA M; OPPENHEIMER F; MORRISSEY RA; NAFTULIN H; CHAPMAN JW; LEVINSON SO
    J Am Med Assoc; 1956 Jun; 161(9):775-81. PubMed ID: 13319005
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization].
    MARTIN R; ROGER F; DAMAS JP; ROGER A; JUILLARD P
    Bull Acad Natl Med; 1961 Nov 21-28; 145():664-73. PubMed ID: 14470436
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on poliomyelitis virus. III. The use of ultra-violet light as an additional means of inactivation of formalinized vaccine.
    HAMPTON JW; POLSON A
    J Hyg (Lond); 1958 Jun; 56(2):266-70. PubMed ID: 13563868
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of antibody following booster dose of poliomyelitis vaccine.
    WILSON RJ; MOSS GW; JACOBS JP; MACLEOD DR
    Can J Public Health; 1962 Jan; 53():17-21. PubMed ID: 14007415
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].
    MORRONE G; NUNZIATA B
    Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315
    [No Abstract]   [Full Text] [Related]  

  • 12. [Poliomyelitis vaccination. Value of a booster injection].
    MARTIN R; DAMAS JP
    Rev Med Fr; 1960 Jan; 41():27-32. PubMed ID: 24546182
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic response to a booster injection following an early vaccination against poliomyelitis].
    BUTLER N
    Rev Immunol Ther Antimicrob; 1960; 24():249-50. PubMed ID: 13806504
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of antibody in adolescents and adults after a third, booster, dose of poliomyelities vaccine.
    KENDALL EJ; BESWICK TS; MILLER A; TOBIN JO
    Br Med J; 1960 Jun; 1(5187):1689-91. PubMed ID: 14408469
    [No Abstract]   [Full Text] [Related]  

  • 15. [Observations on the possible variations of titer of natural anti-poliomyelitis neutralizing antibodies following heterologous immunity stimulation (antidiphtheria booster vaccination)].
    ROSA A; LA PLACA M
    Boll Ist Sieroter Milan; 1959; 38():315-7. PubMed ID: 14438769
    [No Abstract]   [Full Text] [Related]  

  • 16. [Observations on the immunizing effect of small doses of poliomyelitis vaccine inoculated by intradermal route in adult subjects].
    ROSA A; LA PLACA M
    Riv Ital Ig; 1959; 19():143-8. PubMed ID: 14438768
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody response to poliomyelitis vaccine administered by jet injection.
    LIPSON MJ; CARVER DH; ELEFF MG; HINGSON RA; ROBBINS FC
    Am J Public Health Nations Health; 1958 May; 48(5):599-603. PubMed ID: 13521099
    [No Abstract]   [Full Text] [Related]  

  • 18. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of seroimmunity after poliomyelitis vaccination.
    BROWN GC; SMITH DC; PROTHRO WB; ROWE RE
    J Am Med Assoc; 1958 Apr; 166(16):1960-3. PubMed ID: 13525170
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactions to the salk polio vaccine injections of April 1955.
    DAVIS PL
    Med Times; 1956 Jul; 84(7):707-9. PubMed ID: 13347478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.